Cargando…

The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia

OBJECTIVE: Patients with tuberous sclerosis complex (TSC) present with drug‐resistant epilepsy in about 60% of cases, and evaluation for epilepsy surgery may be warranted. Correct delineation of the epileptogenic zone (EZ) among multiple dysplastic lesions on MRI represents a challenging step in pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hulshof, Hanna M., Benova, Barbora, Krsek, Pavel, Kyncl, Martin, Lequin, Maarten H., Belohlavkova, Anezka, Jezdik, Petr, Braun, Kees P. J., Jansen, Floor E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Full‐length Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633464/ https://www.ncbi.nlm.nih.gov/pubmed/34328682 http://dx.doi.org/10.1002/epi4.12529

Ejemplares similares

Commentary on “The epileptogenic zone in children with tuberous sclerosis complex is characterized by prominent features of focal cortical dysplasia”
por: Wong, Michael
Publicado: (2022)

Cognitive performance in distinct groups of children undergoing epilepsy surgery—a single-centre experience
por: Benova, Barbora, et al.
Publicado: (2019)

Defining the latent period of epileptogenesis and epileptogenic zone in a focal cortical dysplasia type II (FCDII) rat model
por: Kao, Hsin‐Yi, et al.
Publicado: (2021)

Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex
por: Huang, Kaixuan, et al.
Publicado: (2022)

Contributions of EEG-fMRI to Assessing the Epileptogenicity of Focal Cortical Dysplasia
por: Pittau, Francesca, et al.
Publicado: (2017)

Seven tesla MRI improves detection of focal cortical dysplasia in patients with refractory focal epilepsy
por: Veersema, Tim J., et al.
Publicado: (2017)

Clinical and anatomical analysis of the epileptogenic spread patterns in focal cortical dysplasia patients
por: Sufianov, Albert, et al.
Publicado: (2023)

Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex
por: Mühlebner, Angelika, et al.
Publicado: (2016)

Correlation of FDG‐PET hypometabolism and SEEG epileptogenicity mapping in patients with drug‐resistant focal epilepsy
por: Lamarche, Florence, et al.
Publicado: (2016)

Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial
por: Kotulska, Katarzyna, et al.
Publicado: (2020)

Pathomorphological Diagnostic Criteria for Focal Cortical Dysplasias and Other Common Epileptogenic Lesions—Review of the Literature
por: Metodiev, Dimitar, et al.
Publicado: (2023)

Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study
por: Moavero, Romina, et al.
Publicado: (2019)

Specific Features of Focal Cortical Dysplasia in Tuberous Sclerosis Complex
por: Bychkova, Ekaterina, et al.
Publicado: (2023)

GABA(A) Receptor-Mediated Epileptogenicity in Focal Cortical Dysplasia (FCD) Depends on Age at Epilepsy Onset
por: Banerjee, Jyotirmoy, et al.
Publicado: (2020)

Validating EEG, MEG and Combined MEG and EEG Beamforming for an Estimation of the Epileptogenic Zone in Focal Cortical Dysplasia
por: Neugebauer, Frank, et al.
Publicado: (2022)

Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with (18)F‐FDG PET‐CT values
por: Wang, Zhongke, et al.
Publicado: (2021)

Epileptogenic but MRI-normal perituberal tissue in Tuberous Sclerosis Complex contains tuber-specific abnormalities
por: Sosunov, Alexander A, et al.
Publicado: (2015)

Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress
por: Zimmer, Till S., et al.
Publicado: (2021)

Calcium‐binding proteins in focal cortical dysplasia
por: Kuchukhidze, Giorgi, et al.
Publicado: (2015)

Towards in vivo focal cortical dysplasia phenotyping using quantitative MRI
por: Adler, Sophie, et al.
Publicado: (2017)

Fast Ripples as a Biomarker of Epileptogenic Tuber in Tuberous Sclerosis Complex Patients Using Stereo-Electroencephalograph
por: Wang, Yangshuo, et al.
Publicado: (2021)

Increased expression of complement components in tuberous sclerosis complex and focal cortical dysplasia type 2B brain lesions
por: Gruber, Victoria‐Elisabeth, et al.
Publicado: (2021)

Interictal epileptogenic zone localization in patients with focal epilepsy using electric source imaging and directed functional connectivity from low‐density EEG
por: Coito, Ana, et al.
Publicado: (2019)

Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex
por: Vergeer, Menno, et al.
Publicado: (2019)

Surgical resection of epileptogenic cortical dysplasia in precentral gyrus()
por: Xue, Hai, et al.
Publicado: (2013)

Bilateral Rasmussen's encephalitis associated with type II focal cortical dysplasia: Dormant ‘second’ epileptogenic zone in contralateral disease()
por: Frigeri, Thomas, et al.
Publicado: (2013)

Dendritic spine loss in epileptogenic Type II focal cortical dysplasia: Role of enhanced classical complement pathway activation
por: Rossini, Laura, et al.
Publicado: (2022)

Localization of the Epileptogenic Foci in Tuberous Sclerosis Complex: A Pediatric Case Report
por: Hunold, Alexander, et al.
Publicado: (2014)

Specific pattern of maturation and differentiation in the formation of cortical tubers in tuberous sclerosis omplex (TSC): evidence from layer-specific marker expression
por: Mühlebner, Angelika, et al.
Publicado: (2016)

Genetic Testing for Malformations of Cortical Development: A Clinical Diagnostic Study
por: Straka, Barbora, et al.
Publicado: (2022)

Automated long‐term EEG analysis to localize the epileptogenic zone
por: van Mierlo, Pieter, et al.
Publicado: (2017)

Transcriptomic profiling of high- and low-spiking regions reveals novel epileptogenic mechanisms in focal cortical dysplasia type II patients
por: Srivastava, Arpna, et al.
Publicado: (2021)

Genomic DNA methylation distinguishes subtypes of human focal cortical dysplasia
por: Kobow, Katja, et al.
Publicado: (2019)

Cortical dysplasia and autistic trait severity in children with Tuberous Sclerosis Complex: a clinical epidemiological study
por: Mous, Sabine E., et al.
Publicado: (2017)

Prediction of Neurodevelopment in Infants With Tuberous Sclerosis Complex Using Early EEG Characteristics
por: De Ridder, Jessie, et al.
Publicado: (2020)

MRI profiling of focal cortical dysplasia using multi‐compartment diffusion models
por: Lorio, Sara, et al.
Publicado: (2020)

Focal Epileptogenic Lesions in Adult Patients with Epilepsy and Generalized Epileptiform Discharges
por: Kim, Dong Wook, et al.
Publicado: (2016)

Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non–mTOR‐mediated etiologies
por: Cepeda, Carlos, et al.
Publicado: (2018)

Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex
por: Scholl, Theresa, et al.
Publicado: (2017)

Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia
por: Leitner, Dominique F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l8c654o1ro9uh8sluqepckghlf